OptimizeRx/OPRX

$15.95

0.75%
-
1D1W1MYTD1YMAX

About OptimizeRx

OptimizeRx Corporation is a digital health technology company, which enables engagement between life sciences organizations, healthcare providers and patients. The Company's principal solutions include evidence-based physician engagement, point of care banner messaging, social network banner messaging, institutional account-based banner messaging, financial messaging, patient engagement and therapy initiation workflow. Its evidence-based physician engagement solution uses predictive analytics via machine learning methods applied to real-world data (RWD) to assist healthcare providers (HCPs). Its point of care banner messaging solution utilizes to deliver a variety of awareness and messaging within the clinical workflow, which can be tailored to meet the needs of each brand. Its Institutional Account-based Banner Messaging solution provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts.

Ticker

OPRX

Sector

Technology

Trading on

NASDAQ

Industry

Advertising

CEO

William Febbo

Employees

109

Headquarters

Waltham, United States

OptimizeRx Metrics

BasicAdvanced
$289.53M
Market cap
-
P/E ratio
-$0.81
EPS
1.01
Beta
-
Dividend rate

What the Analysts think about OptimizeRx

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 5 analysts.
2.82% upside
High $20.00
Low $13.00
$15.95
Current price
$16.40
Average price target

OptimizeRx Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-17.17% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$16.3M
18.12%
Net income
$-2.8M
-31.71%
Profit margin
-17.17%
-42.21%

OptimizeRx Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 260%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$0.25
-$0.09
-$0.01
$0.09
-
Expected
$0.24
-$0.08
-$0.02
$0.03
$0.26
Surprise
3.55%
12.5%
-53.33%
260%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell OptimizeRx stock

Buy or sell OptimizeRx stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing